Enthera Pharmaceuticals
- Website
- entherapharmaceuticals.com
- Total Funding
- $73.7M
- Last Round
- $38.5M Series AJan 2021
- Rounds
- 3
About
TWEAK pathway inhibitor for autoimmune diseases
Summary
It has raised $73.7M in total across 3 rounds, most recently a $38.5M Series A round in Jan 2021. Investors include Sofinnova Partners, AbbVie Ventures and JDRF T1D Fund.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
$38.5M
Jan 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.